Policlínica Gipuzkoa

[The BMJ published an "expression of concern" about this study on November 12] A phase 3 clinical trial has analyzed the effectiveness of administering stem cells to prevent heart failure in people who have suffered a major heart attack. The trial included 396 patients, 136 of whom received a stem cell infusion. According to the results, published in The BMJ, the treatment significantly reduced the rates of heart failure, although it did not affect mortality.